Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03240874 · ClinicalTrials.gov registry record · NA
SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
A NA study of Diabetes Mellitus in Pregnancy, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03240874: Completed NA study of Diabetes Mellitus in Pregnancy, sponsored by Northwestern University.
NCT03240874 is a NA study of Diabetes Mellitus in Pregnancy that has completed, run by Northwestern University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03240874, a NA study of Diabetes Mellitus in Pregnancy, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Diabetes during pregnancy is a challenging clinical situation requiring substantial patient engagement. The investigators have developed a novel early-phase tool, called SweetMama, that incorporates educational, motivational and supportive elements to positively impact maternal health behaviors. This phase of work involves develop an optimized version of SweetMama via a 2-step sequential process of in-depth usability and feasibility testing. First the investigators will conduct focus groups and individual usability testing followed by refinement of SweetMama based on participant input. Next, the investigators will conduct feasibility testing via a pilot randomized trial to determine acceptability, feasibility, and pilot procedures for a fully powered larger trial.
Primary Outcome
Participants completed qualitative group interviews to yield information about SweetMama features and participant preferences after use in the usability laboratory. The identified themes are outlined, and the criteria used to determine the outcome measure is the number of participants who endorsed each theme related to SweetMama features.
Conditions Studied
Interventions
- BEHAVIORAL SweetMama Focus Groups
- BEHAVIORAL SweetMama Individual Testing
- BEHAVIORAL SweetMama Feasibility Testing - Pilot Randomized Trial
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
What the finished NCT03240874 record still lists
NCT03240874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 3 interventions - of which SweetMama Focus Groups is the first listed.
NCT03240874 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03240874 about?
NCT03240874 is a clinical study titled "SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women". Diabetes during pregnancy is a challenging clinical situation requiring substantial patient engagement. The investigators have developed a novel early-phase tool, called SweetMama, that incorporates educational, motivational and supportive elements to positively impact maternal health behaviors. Thi...
What is the current status of trial NCT03240874?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-08-02. Estimated completion is 2021-04-09.
What conditions does trial NCT03240874 study?
This clinical trial studies the following conditions: Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT03240874?
The interventions under investigation include: SweetMama Focus Groups (BEHAVIORAL), SweetMama Individual Testing (BEHAVIORAL), SweetMama Feasibility Testing - Pilot Randomized Trial (BEHAVIORAL).
Who is sponsoring clinical trial NCT03240874?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03240874 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03240874's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI